Clinical Trial Categories
MDS Trials
USO 20178
Avavilable at 12 locations
A Randomized, Open-Label, Phase 3 Study Evaluating the Safety and Efficacy of Venetoclax in Combination with Azacitidine in Patients Newly Diagnosed with Higher-Risk Myelodysplastic Syndrome (HR-MDS)
